ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Computer Interpretation Software Does Not Improve Detection

August 26, 2011

Conferees Stalled On Money Bill, Running Out Of Time

September 17, 1976

Nixon National Cancer Conference Kicks Off

December 8, 2021

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

Surveillance Colonoscopy Cost-Effective For High-Risk

July 30, 2010

NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion

November 4, 1994